Français 200 jobs created at Evotec
The Evotec group has chosen Toulouse for its future biopharmaceutical plant which will not produce drugs of chemical origin, but drugs of biological origin. It could be operational by 2023 and should enable the creation of 200 jobs. This new 12,000 m² factory will manufacture drugs mainly for other laboratories. In all, this represents an investment of 150 million euros, of which a third will be provided by the State, the Occitanie region and Toulouse Métropole.
Le 04 mai 2021 par Gl events
Our other news
See all
Join the largest community of industrial suppliers
- Helping you with your ongoing technology watch
- Provide you with detailed supplier statistics
- Give you international visibility
Discover the largest catalogue of industrial products on the market
- To offer you the best catalogue of industrial products on the market
- To guarantee you a 100% secure platform
- Enable you to have live remote exchanges